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There is great enthusiasm for the use of biologic therapies to treat a range of musculoskeletal injuries and pathologies.^[@bibr1-2046-3758.79.BJR-2017-0360],[@bibr2-2046-3758.79.BJR-2017-0360]^ The ability for mesenchymal stem cells (MSCs) to differentiate into multiple cell types and release pro-regenerative growth factors holds great promise for musculoskeletal tissue engineering.^[@bibr3-2046-3758.79.BJR-2017-0360],[@bibr4-2046-3758.79.BJR-2017-0360]^ However, their clinical benefits are not yet clear. A large number of factors including donor variables, tissue source, processing and laboratory conditions, and pathology timing influence the effect of biologic therapies.^[@bibr5-2046-3758.79.BJR-2017-0360]-[@bibr7-2046-3758.79.BJR-2017-0360]^ Many emerging clinical trials evaluating biologics do not report sufficient scientific details, including processing and characterization, which may critically impact outcome.^[@bibr8-2046-3758.79.BJR-2017-0360]^ Inadequate reporting of scientific details limits the readers' ability to interpret findings, makes replication by others challenging and prevents comparison across studies.^[@bibr9-2046-3758.79.BJR-2017-0360]^

To encourage improved reporting, minimum standards of reporting specific to stem cells have recently been developed.^[@bibr10-2046-3758.79.BJR-2017-0360]^ In an international effort by clinicians and scientists, a consensus on the minimum reporting guidelines for clinical studies evaluating MSCs was achieved using Delphi Consensus Methods (so called [M]{.ul}inimum [I]{.ul}nformation for [B]{.ul}i[o]{.ul}logics or *MIBO*).^[@bibr10-2046-3758.79.BJR-2017-0360]^ Adoption of such checklists will help improve experimental transparency and repeatability, promote standardization and encourage a wider collaborative effort.
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